$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000143774920018059 Filed on August 14, 2020

Income Statement

Concept	2020 Q2	2020 Q1	2019 Q2
Revenue	$307.1K	$522.5K	$728.4K
YoY Change	-57.83%	-5.28%	-2.64%
Cost Of Revenue	$148.5K	$124.3K	$679.4K
YoY Change	-78.15%	-79.43%	-34.02%
Gross Profit	$158.7K	$398.2K	$48.96K
YoY Change	224.14%	-859.57%	-117.38%
Gross Profit Margin	51.67%	76.22%	6.72%
Selling, General & Admin	$1.212M	$1.381M	$1.059M
YoY Change	14.48%	0.32%	-1.63%
% of Gross Profit	763.72%	346.89%	2162.45%
Research & Development	$318.6K	$336.9K	$301.2K
YoY Change	5.76%	-9.95%	1.2%
% of Gross Profit	200.75%	84.6%	615.27%
Depreciation & Amortization	$20.00K	$19.91K	$310.0K
YoY Change	-93.55%	3.21%	-54.41%
% of Gross Profit	12.6%	5.0%	633.21%
Operating Expenses	$1.531M	$1.718M	$1.360M
YoY Change	12.55%	-1.88%	-1.01%
Operating Profit	-$200.9K	-$2.050M	-$114.8K
YoY Change	74.98%	-2928980.0%	-93.06%
Interest Expense	$567.5K	$1.551M	$114.9K
YoY Change	394.07%
% of Operating Profit
Other Income/Expense, Net	-$1.372M	-$1.320M	-$1.311M
YoY Change	4.64%	-26.81%
Pretax Income	-$1.570M	-$3.370M	-$1.430M
YoY Change	9.79%	87.22%	-13.86%
Income Tax
% Of Pretax Income
Net Earnings	-$1.573M	-$3.370M	-$1.426M
YoY Change	10.31%	86.87%	-13.88%
Net Earnings / Revenue	-512.05%	-645.05%	-195.74%
Basic Earnings Per Share
Diluted Earnings Per Share	-$601.5K	-$1.774M	-$812.5K
COMMON SHARES
Basic Shares Outstanding	21.60M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q2	2020 Q1	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.400M	$1.170M	$690.0K
YoY Change	102.9%	154.35%	130.0%
Cash & Equivalents	$886.7K	$661.9K	$687.0K
Short-Term Investments	$520.0K	$510.0K
Other Short-Term Assets	$79.63K	$130.7K	$138.6K
YoY Change	-42.53%	72.33%	400.91%
Inventory	$388.9K	$388.9K	$1.012M
Prepaid Expenses
Receivables	$315.3K	$120.3K	$689.9K
Other Receivables	$70.00K	$130.0K	$140.0K
Total Short-Term Assets	$2.285M	$1.990M	$3.814M
YoY Change	-40.08%	-44.05%	-19.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$95.55K	$75.60K	$137.5K
YoY Change	-30.49%	-50.5%	-27.41%
Goodwill	$417.2K
YoY Change
Intangibles	$2.147M	$147.2K	$191.0K
YoY Change	1024.1%	-24.24%	1.7%
Long-Term Investments
YoY Change
Other Assets	$190.0K	$220.0K	$290.0K
YoY Change	-34.48%	-29.03%	-17.14%
Total Long-Term Assets	$3.467M	$1.029M	$7.342M
YoY Change	-52.78%	-86.64%	-6.75%
TOTAL ASSETS
Total Short-Term Assets	$2.285M	$1.990M	$3.814M
Total Long-Term Assets	$3.467M	$1.029M	$7.342M
Total Assets	$5.752M	$3.019M	$11.16M
YoY Change	-48.44%	-75.42%	-11.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$668.5K	$617.0K	$864.9K
YoY Change	-22.71%	30.54%	161.74%
Accrued Expenses	$380.5K	$515.1K	$714.3K
YoY Change	-46.73%	-10.88%	47.4%
Deferred Revenue	$602.8K	$413.3K	$294.3K
YoY Change	104.85%	24.04%	-10.34%
Short-Term Debt	$500.0K	$2.370M	$540.0K
YoY Change	-7.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.623M	$4.077M	$2.699M
YoY Change	71.32%	146.28%	136.07%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$350.0K	$350.0K	$380.0K
YoY Change	-7.89%	-16.67%
Total Long-Term Liabilities	$346.1K	$353.6K	$383.0K
YoY Change	-9.65%	-15.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.623M	$4.077M	$2.699M
Total Long-Term Liabilities	$346.1K	$353.6K	$383.0K
Total Liabilities	$4.970M	$4.430M	$3.082M
YoY Change	61.26%	143.9%	169.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$94.78M	-$93.21M	-$78.36M
YoY Change	20.95%	21.14%	10.86%
Common Stock	$2.218K	$1.839K	$1.429K
YoY Change	55.21%	31.45%	13.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$782.5K	-$1.411M	$8.074M
YoY Change
Total Liabilities & Shareholders Equity	$5.752M	$3.019M	$11.16M
YoY Change	-48.44%	-75.42%	-11.49%

Cashflow Statement

Concept	2020 Q2	2020 Q1	2019 Q2
OPERATING ACTIVITIES
Net Income	-$1.573M	-$3.370M	-$1.426M
YoY Change	10.31%	86.87%	-13.88%
Depreciation, Depletion And Amortization	$20.00K	$19.91K	$310.0K
YoY Change	-93.55%	3.21%	-54.41%
Cash From Operating Activities	-$950.0K	-$1.023M	-$420.0K
YoY Change	126.19%	-737.28%	-55.32%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		-$10.00K
YoY Change	-100.0%		-75.0%
Acquisitions
YoY Change
Other Investing Activities	-$1.900M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$1.910M		$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.070M	1.606M	650.0K
YoY Change	372.31%		-3350.0%
NET CHANGE
Cash From Operating Activities	-950.0K	-1.023M	-420.0K
Cash From Investing Activities	-1.910M		0.000
Cash From Financing Activities	3.070M	1.606M	650.0K
Net Change In Cash	210.0K	582.9K	230.0K
YoY Change	-8.7%	330.62%	-123.0%
FREE CASH FLOW
Cash From Operating Activities	-$950.0K	-$1.023M	-$420.0K
Capital Expenditures	$0.00		-$10.00K
Free Cash Flow	-$950.0K	-$1.023M	-$410.0K
YoY Change	131.71%	-846.0%	-54.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Central Index Key EntityCentralIndexKey	0001019034
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q2	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	199328
	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	641215
	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	562150
	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	641215
	bkyi	Beneficial Conversion Feature BeneficialConversionFeature
	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	184792
	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired
	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired	494
	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired
	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired	253168
	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired
	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	36467
	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired
	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	2005000
	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired
	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable	500000
	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable
	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired	9485
	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662
CY2020Q1	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-900000
CY2019Q2	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-270000
	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote	551250
	bkyi	Debt Discount Issued With Convertible Note DebtDiscountIssuedWithConvertibleNote	40000
CY2020Q1	bkyi	Deemed Dividend Related To Down Round Features DeemedDividendRelatedToDownRoundFeatures
CY2020Q2	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-109403
CY2019Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-122064
CY2020Q2	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	189037
CY2019Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	233005
	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2020Q2	bkyi	Factoring Fees FactoringFees	33230
CY2019Q2	bkyi	Factoring Fees FactoringFees	39543
	bkyi	Factoring Fees FactoringFees	65230
	bkyi	Factoring Fees FactoringFees	92340
CY2020Q2	bkyi	Government Grant Income GovernmentGrantIncome	340819
CY2019Q2	bkyi	Government Grant Income GovernmentGrantIncome
	bkyi	Government Grant Income GovernmentGrantIncome	340819
	bkyi	Government Grant Income GovernmentGrantIncome
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	18486
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	26861
	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-89787
	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-66246
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-5028
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-35043
CY2019	bkyi	Investment In Held To Maturity Debt Securities Term InvestmentInHeldToMaturityDebtSecuritiesTerm	P1Y
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q4	bkyi	Investment In Heldtomaturity Debt Securities Interest Rate InvestmentInHeldtomaturityDebtSecuritiesInterestRate	0.05
CY2020Q2	bkyi	Investment In Heldtomaturity Debt Securities Interest Rate InvestmentInHeldtomaturityDebtSecuritiesInterestRate	0.05
	bkyi	Legal And Commitment Fees Related To Debt And Equity Included In Accounts Payable LegalAndCommitmentFeesRelatedToDebtAndEquityIncludedInAccountsPayable	122714
	bkyi	Legal And Commitment Fees Related To Debt And Equity Included In Accounts Payable LegalAndCommitmentFeesRelatedToDebtAndEquityIncludedInAccountsPayable
CY2020Q2	bkyi	Limit Of Bond LimitOfBond	20000000
	bkyi	Monthly Cash Requirement To Conduct Operations And Pay Dividend Obligations MonthlyCashRequirementToConductOperationsAndPayDividendObligations	680000
	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	79107
	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	590342
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330
	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
CY2019	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	640551
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	635077
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	277833
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	180000
CY2020Q2	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	68774
CY2019Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	73802
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	15007
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	22011
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	266667
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	114943
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	136575
CY2020Q1	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	1458000
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	133333
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	100000
	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	1388339
	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	572885
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95558928
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87436402
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	641215
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	512719
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33177
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	509528
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	125549
	dei	Entity Registrant Name EntityRegistrantName	BIO KEY INTERNATIONAL INC
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Trading Symbol TradingSymbol	bkyi
CY2020Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	79634
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	110941
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	668474
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	844557
CY2020Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2049126
CY2019Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1859785
CY2020Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	329126
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	139785
CY2020Q2	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2019Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2020Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	315341
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	126000
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	315341
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126000
CY2020Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	380462
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	142839
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	131054
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	655558
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	657088
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	398929
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	15467
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	981529
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	56200
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12189
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6628
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6957516
CY2020Q2	us-gaap	Assets Assets	5751997
CY2019Q4	us-gaap	Assets Assets	2496698
CY2020Q2	us-gaap	Assets Current AssetsCurrent	2285299
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1366291
CY2020Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	3466698
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1130407
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	73660
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	67774
CY2020Q2	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	100747
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	886664
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79013
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79013
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	323943
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	886664
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	687023
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	807651
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	363080
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.65
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22181315
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14411432
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22181315
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14411432
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	2218
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1441
CY2020Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	176345
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	231519
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	602779
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	359212
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	602779
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	359212
CY2020Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	36000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	108000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	148454
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	679426
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	272717
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1283476
CY2020Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
	us-gaap	Depreciation Depreciation	39919
	us-gaap	Depreciation Depreciation	39903
CY2020Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind	41688
	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686
	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020Q2	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2019Q2	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	66466
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	188737
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-192917
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	166018
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-9601
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	97652
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-40221
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12874
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-31307
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q2	us-gaap	Goodwill Goodwill	417171
CY2019Q4	us-gaap	Goodwill Goodwill
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	417171
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod
CY2020Q2	us-gaap	Gross Profit GrossProfit	158688
CY2019Q2	us-gaap	Gross Profit GrossProfit	48957
	us-gaap	Gross Profit GrossProfit	556910
	us-gaap	Gross Profit GrossProfit	-3470
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000000
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2020Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000000
CY2020Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	516121
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-298797
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	526233
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4549
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-884132
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	81886
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19241
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23781
CY2020Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2147197
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	154386
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	96984
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized
CY2020Q2	us-gaap	Interest Expense InterestExpense	567516
CY2019Q2	us-gaap	Interest Expense InterestExpense	114866
	us-gaap	Interest Expense InterestExpense	2118657
	us-gaap	Interest Expense InterestExpense	114866
	us-gaap	Interest Paid Net InterestPaidNet
	us-gaap	Interest Paid Net InterestPaidNet
CY2020Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	247540
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	287761
CY2020Q2	us-gaap	Inventory Net InventoryNet	388898
CY2019Q4	us-gaap	Inventory Net InventoryNet	429119
CY2020Q1	us-gaap	Inventory Net InventoryNet	388898
CY2020Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	25800
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1371813
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1310931
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2691879
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3114509
CY2020Q2	us-gaap	Notes Payable Current NotesPayableCurrent	2201017
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	25801
CY2019Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	54
	us-gaap	Investment Income Interest InvestmentIncomeInterest	25802
	us-gaap	Investment Income Interest InvestmentIncomeInterest	124
CY2020Q2	us-gaap	Lease Cost LeaseCost	53723
	us-gaap	Lease Cost LeaseCost	107445
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	597181
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	223377
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	89226
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	165194
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	119384
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	46835
CY2020Q2	us-gaap	Liabilities Liabilities	4969544
CY2019Q4	us-gaap	Liabilities Liabilities	4781871
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5751997
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2496698
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4623480
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4391405
CY2020Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	346064
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	390466
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4683333
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	650000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1906042
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30489
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1969640
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-256431
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3370282
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1572709
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1803508
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1425743
	us-gaap	Net Income Loss NetIncomeLoss	-4942991
	us-gaap	Net Income Loss NetIncomeLoss	-3229251
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1572709
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1425743
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5055677
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3229251
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2255454
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	1530501
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	1359888
	us-gaap	Operating Expenses OperatingExpenses	3248789
	us-gaap	Operating Expenses OperatingExpenses	3111039
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-200896
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-114812
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2251112
	us-gaap	Operating Income Loss OperatingIncomeLoss	-114742
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	53723
	us-gaap	Operating Lease Cost OperatingLeaseCost	107445
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	550346
CY2020Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204282
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170560
CY2020Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	346064
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	390466
	us-gaap	Operating Lease Payments OperatingLeasePayments	104602
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	552954
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	566479
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	92632
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	70180
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y273D
CY2020Q2	us-gaap	Other Assets Current OtherAssetsCurrent	79634
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110941
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	398412
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	17000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2000000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1736
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	516121
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3489
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28753
CY2020Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	98641
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108397
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;">Reclassification</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Reclassifications occurred to certain prior year amounts in order to conform to the current year classifications.  The reclassifications have <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the reported net loss.</div></div></div></div></div></div></div>
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3958000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	667000
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-122271
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	512821
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95545
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95509
	us-gaap	Stock Issued1 StockIssued1
CY2019Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	728383
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	829627
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1280006
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	211984
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	318573
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	301217
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	655462
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	675335
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-94778693
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89723016
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	307142
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.16
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.7322
CY2020Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	500000
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1211928
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1058671
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2593327
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2435704
CY2020Q1	us-gaap	Share Price SharePrice	0.76
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	552954
	us-gaap	Stock Issued1 StockIssued1	3789000
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1500000
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2289000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1032500
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	145333
CY2019Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	450000
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15007
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16506
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5505
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	782453
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-1411021
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	9188748
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	8074059
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20864866
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14117062
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18030939
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14048570

Files In Submission

Name	View Source	Status
0001437749-20-018059-index-headers.html	Edgar Link	pending
0001437749-20-018059-index.html	Edgar Link	pending
0001437749-20-018059.txt	Edgar Link	pending
0001437749-20-018059-xbrl.zip	Edgar Link	pending
bkyi-20200630.xml	Edgar Link	completed
bkyi-20200630.xsd	Edgar Link	pending
bkyi-20200630_cal.xml	Edgar Link	unprocessable
bkyi-20200630_def.xml	Edgar Link	unprocessable
bkyi-20200630_lab.xml	Edgar Link	unprocessable
bkyi-20200630_pre.xml	Edgar Link	unprocessable
bkyi20200630_10q.htm	Edgar Link	pending
ex_198407.htm	Edgar Link	pending
ex_198408.htm	Edgar Link	pending
ex_198409.htm	Edgar Link	pending
ex_198410.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2020 Q2 Form 10-Q Financial Statement

#000143774920018059 Filed on August 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2020 Q2 Form 10-Q Financial Statement

#000143774920018059 Filed on August 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi